JP2019178177A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019178177A5 JP2019178177A5 JP2019137721A JP2019137721A JP2019178177A5 JP 2019178177 A5 JP2019178177 A5 JP 2019178177A5 JP 2019137721 A JP2019137721 A JP 2019137721A JP 2019137721 A JP2019137721 A JP 2019137721A JP 2019178177 A5 JP2019178177 A5 JP 2019178177A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- administration
- oral
- continuous infusion
- cangrelor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 13
- 238000001802 infusion Methods 0.000 claims 7
- 229960001080 cangrelor Drugs 0.000 claims 6
- PAEBIVWUMLRPSK-IDTAVKCVSA-N cangrelor Chemical compound C1=NC=2C(NCCSC)=NC(SCCC(F)(F)F)=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]1O PAEBIVWUMLRPSK-IDTAVKCVSA-N 0.000 claims 6
- 229960002528 ticagrelor Drugs 0.000 claims 5
- OEKWJQXRCDYSHL-FNOIDJSQSA-N ticagrelor Chemical compound C1([C@@H]2C[C@H]2NC=2N=C(N=C3N([C@H]4[C@@H]([C@H](O)[C@@H](OCCO)C4)O)N=NC3=2)SCCC)=CC=C(F)C(F)=C1 OEKWJQXRCDYSHL-FNOIDJSQSA-N 0.000 claims 5
- 239000003112 inhibitor Substances 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 238000013146 percutaneous coronary intervention Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 claims 1
- 239000005465 B01AC22 - Prasugrel Substances 0.000 claims 1
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 1
- 229960003009 clopidogrel Drugs 0.000 claims 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 238000011866 long-term treatment Methods 0.000 claims 1
- 229960004197 prasugrel Drugs 0.000 claims 1
- DTGLZDAWLRGWQN-UHFFFAOYSA-N prasugrel Chemical compound C1CC=2SC(OC(=O)C)=CC=2CN1C(C=1C(=CC=CC=1)F)C(=O)C1CC1 DTGLZDAWLRGWQN-UHFFFAOYSA-N 0.000 claims 1
- 239000008354 sodium chloride injection Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/792,056 | 2013-03-09 | ||
| US13/792,056 US9427448B2 (en) | 2009-11-11 | 2013-03-09 | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
| US201361815735P | 2013-04-25 | 2013-04-25 | |
| US61/815,735 | 2013-04-25 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017197488A Division JP2018002739A (ja) | 2013-03-09 | 2017-10-11 | 虚血性事象を処置し、その発生率を低減させ、かつ／または予防する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019178177A JP2019178177A (ja) | 2019-10-17 |
| JP2019178177A5 true JP2019178177A5 (enExample) | 2019-12-26 |
| JP6840197B2 JP6840197B2 (ja) | 2021-03-10 |
Family
ID=51537409
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561314A Active JP6247708B2 (ja) | 2013-03-09 | 2013-05-29 | 虚血性事象を処置し、その発生率を低減させ、かつ／または予防する方法 |
| JP2017197488A Withdrawn JP2018002739A (ja) | 2013-03-09 | 2017-10-11 | 虚血性事象を処置し、その発生率を低減させ、かつ／または予防する方法 |
| JP2019137721A Active JP6840197B2 (ja) | 2013-03-09 | 2019-07-26 | 虚血性事象を処置し、その発生率を低減させ、かつ／または予防する方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561314A Active JP6247708B2 (ja) | 2013-03-09 | 2013-05-29 | 虚血性事象を処置し、その発生率を低減させ、かつ／または予防する方法 |
| JP2017197488A Withdrawn JP2018002739A (ja) | 2013-03-09 | 2017-10-11 | 虚血性事象を処置し、その発生率を低減させ、かつ／または予防する方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP2964233B1 (enExample) |
| JP (3) | JP6247708B2 (enExample) |
| CN (2) | CN115120606A (enExample) |
| AU (1) | AU2013381855B2 (enExample) |
| BR (1) | BR112015022070B1 (enExample) |
| CA (1) | CA2904523C (enExample) |
| EA (1) | EA034550B1 (enExample) |
| ES (1) | ES2904256T3 (enExample) |
| PL (1) | PL2964233T3 (enExample) |
| WO (1) | WO2014143107A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013381855B2 (en) * | 2013-03-09 | 2018-08-02 | Chiesi Farmaceutici S.P.A. | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
| WO2018234565A1 (en) | 2017-06-23 | 2018-12-27 | Chiesi Farmaceutici S.P.A. | METHOD FOR PREVENTING SHUNT THROMBOSIS FROM THE SYSTEMIC-PULMONARY ARTERY |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK281309B6 (sk) | 1993-02-10 | 2001-02-12 | Astra Pharmaceuticals Limited | N-alkyl-2-substituované adenozíntrifosfátové deriváty, spôsob ich prípravy, farmaceutické prostriedky obsahujúce tieto deriváty a použitie týchto derivátov |
| ID21635A (id) | 1996-12-20 | 1999-07-08 | Astra Pharma Prod | Komposisi farmasi untuk pengeringan beku |
| SE9702680D0 (sv) | 1997-07-11 | 1997-07-11 | Astra Pharma Prod | New formulation |
| SE9904377D0 (sv) | 1999-12-01 | 1999-12-01 | Astra Pharma Prod | Pharmaceutical combinations |
| WO2009140092A1 (en) * | 2008-05-13 | 2009-11-19 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
| US9427448B2 (en) * | 2009-11-11 | 2016-08-30 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
| US20100297675A1 (en) * | 2008-11-24 | 2010-11-25 | Huayun Deng | Substrate and method for culturing breast cells |
| JP5851246B2 (ja) * | 2008-12-30 | 2016-02-03 | リグスホスピタルＲｉｇｓｈｏｓｐｉｔａｌｅｔ | 臓器不全の発生リスクが上昇した重篤患者を識別する方法およびその治療のための化合物 |
| PT2443120T (pt) * | 2009-06-16 | 2017-02-08 | Rspr Pharma Ab | Forma cristalina de pemirolast |
| BR112012011298B1 (pt) * | 2009-11-11 | 2021-12-14 | Chiesi Farmaceutici S.P.A. | Uso de cangrelor e/ou bivalirudina na preparação de medicamentos e combinação de medicamentos |
| AU2013381855B2 (en) * | 2013-03-09 | 2018-08-02 | Chiesi Farmaceutici S.P.A. | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
-
2013
- 2013-05-29 AU AU2013381855A patent/AU2013381855B2/en active Active
- 2013-05-29 WO PCT/US2013/043136 patent/WO2014143107A1/en not_active Ceased
- 2013-05-29 EP EP13878203.2A patent/EP2964233B1/en active Active
- 2013-05-29 CN CN202210682855.1A patent/CN115120606A/zh active Pending
- 2013-05-29 CN CN201380076382.XA patent/CN106102750A/zh active Pending
- 2013-05-29 EP EP21205348.2A patent/EP3978002A1/en active Pending
- 2013-05-29 ES ES13878203T patent/ES2904256T3/es active Active
- 2013-05-29 CA CA2904523A patent/CA2904523C/en active Active
- 2013-05-29 JP JP2015561314A patent/JP6247708B2/ja active Active
- 2013-05-29 PL PL13878203T patent/PL2964233T3/pl unknown
- 2013-05-29 EA EA201591683A patent/EA034550B1/ru unknown
- 2013-05-29 BR BR112015022070-3A patent/BR112015022070B1/pt active IP Right Grant
-
2017
- 2017-10-11 JP JP2017197488A patent/JP2018002739A/ja not_active Withdrawn
-
2019
- 2019-07-26 JP JP2019137721A patent/JP6840197B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023088944A5 (enExample) | ||
| US11607389B2 (en) | Delayed release deferiprone tablets and methods of using the same | |
| EP0893998A1 (en) | Colonic delivery of nicotine to treat inflammatory bowel disease | |
| JP2023535744A5 (enExample) | ||
| JP2022548575A5 (enExample) | ||
| JP2025148449A5 (enExample) | ||
| JP2020510043A5 (enExample) | ||
| CN113274384A (zh) | 驴食草酚在制备防治溃疡性结肠炎的药物中的应用及其药物 | |
| JP2016505050A5 (enExample) | ||
| JP2007501806A5 (enExample) | ||
| JP2019509309A5 (enExample) | ||
| CN110035751A (zh) | 一种维利帕尼缓控释药物组合物及其用途 | |
| JP2016510738A5 (enExample) | ||
| WO2020183020A1 (en) | Capsid assembly modulator solid formulation | |
| JP7376679B2 (ja) | Ｈｂｖ感染の処置のためのｅｙｐ００１とｉｆｎの相乗効果 | |
| JP2012025734A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
| JP2022540854A5 (enExample) | ||
| JP2023537921A5 (enExample) | ||
| JP2023507764A5 (enExample) | ||
| HK40066536B (en) | Synergistic effect of eyp001 and pegylated ifn-alpha for the treatment of hbv infection | |
| HK40065231A (zh) | 延迟释放去铁酮片剂及其使用方法 | |
| HK40014065B (en) | Terlipressin composition for use in treating ascites | |
| HK40014065A (en) | Terlipressin composition for use in treating ascites |